Clinical provision of improvised nasal naloxone without experimental testing and without regulatory...
Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
About this item
Full title
Author / Creator
Publisher
England: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Context
Take‐home naloxone is increasingly provided to prevent heroin overdose deaths. Naloxone 0.4–2.0 mg is licensed for use by injection. Some clinicians supply improvised nasal naloxone kits (outside lisenced approval). Is this acceptable?
Aims
(1) To consider provision of improvised nasal naloxone in clinical practice and (2) to searc...
Alternative Titles
Full title
Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1811846146
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1811846146
Other Identifiers
ISSN
0965-2140
E-ISSN
1360-0443
DOI
10.1111/add.13209
